Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

'Breaking: Lilly And Novo Near White House Deal On Obesity Drug Prices; Under The Deal, Which Could Be Announced This Week, They Would Offer The Lowest Dose Of Their Obesity Drugs At $149 Per Month. In Return, The Products Would Gain Coverage Under Medicare, Opening Up A Huge New Set Of Reimbursement' - Endpoints News

Author: Benzinga Newsdesk | November 04, 2025 10:25am

Posted In: LLY NVO SPY